Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Breast Cancer Research and Treatment
|
October 12, 1999
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal
M Federico, A Maiorana, L Mangone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2000
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy
R Sabbatini, M Federico, M Morselli, et al.
Haematologica
|
February 1, 1982
Castleman's lymphoadenopathy: twenty years of observation. I. General considerations. Monoadenopathic variety
T Artusi, A Saragoni, G Bonacorsi, et al.
Tumori
|
December 31, 1984
A report of seven long survivors for evidence of prognostic factors in hairy cell leukemia
M Federico, F Barbieri, D Dini, et al.
Haematologica
|
December 29, 1998
Retrospective analysis of mantle cell lymphoma: experience of the "Gruppo Italiano per lo Studio dei Linfomi" (GISL)
V Callea, V Clò, F Morabito, et al.
American Journal of Clinical Oncology
|
February 1, 1995
Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. A report from the Italian Lymphoma Study Group (GISL)
M Federico, P G Gobbi, G Moretti, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1989
Bone marrow infiltration in hairy cell leukemia after interferon therapy detected by magnetic resonance imaging
V Silingardi, S Davolio-Marani, M Federico, et al.
Minerva Medica
|
September 5, 1970
[L-asparaginase in the treatment of acute leukoses]
E Storti, G Fontana, E Ascari, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1991
Methotrexate, vinblastine, epidoxorubicin and cisplatin (M-VEC) in patients with locally advanced transitional bladder cancer
A Frassoldati, M Federico, F Barbieri, et al.
Genes, Chromosomes & Cancer
|
December 29, 1999
Comparison between genotype and phenotype identifies a high-risk population carrying BRCA1 mutations
L Cortesi, D Turchetti, C Bertoni, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Breast Cancer Research and Treatment
|
October 12, 1999
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal
M Federico, A Maiorana, L Mangone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2000
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy
R Sabbatini, M Federico, M Morselli, et al.
Haematologica
|
February 1, 1982
Castleman's lymphoadenopathy: twenty years of observation. I. General considerations. Monoadenopathic variety
T Artusi, A Saragoni, G Bonacorsi, et al.
Tumori
|
December 31, 1984
A report of seven long survivors for evidence of prognostic factors in hairy cell leukemia
M Federico, F Barbieri, D Dini, et al.
Haematologica
|
December 29, 1998
Retrospective analysis of mantle cell lymphoma: experience of the "Gruppo Italiano per lo Studio dei Linfomi" (GISL)
V Callea, V Clò, F Morabito, et al.
American Journal of Clinical Oncology
|
February 1, 1995
Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. A report from the Italian Lymphoma Study Group (GISL)
M Federico, P G Gobbi, G Moretti, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1989
Bone marrow infiltration in hairy cell leukemia after interferon therapy detected by magnetic resonance imaging
V Silingardi, S Davolio-Marani, M Federico, et al.
Minerva Medica
|
September 5, 1970
[L-asparaginase in the treatment of acute leukoses]
E Storti, G Fontana, E Ascari, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1991
Methotrexate, vinblastine, epidoxorubicin and cisplatin (M-VEC) in patients with locally advanced transitional bladder cancer
A Frassoldati, M Federico, F Barbieri, et al.
Genes, Chromosomes & Cancer
|
December 29, 1999
Comparison between genotype and phenotype identifies a high-risk population carrying BRCA1 mutations
L Cortesi, D Turchetti, C Bertoni, et al.
Page
of 8